Table 4.
Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder SC/ASC patients
| Clinicopathological features | Case number | Average survival (months) | χ2 | P |
|---|---|---|---|---|
| Gender |
|
|
|
|
| male |
19 |
10.74(6 to 24) |
0.767 |
0.381 |
| female |
27 |
9.85(4 to 24) |
|
|
| Age (years) |
|
|
|
|
| ≤45 |
3 |
15.67(8 to 24) |
2.023 |
0.155 |
| >45 |
43 |
9.84(4 to 24) |
|
|
| Pathological types |
|
|
|
|
| SC |
26 |
10.19(4 to 24) |
0.223 |
0.637 |
| ASC |
20 |
10.25(4 to 24) |
|
|
| Degree of differentiationa |
|
|
|
|
| well-differentiated |
16 |
7.04(4 to 11) |
|
|
| moderately-Differentiated |
24 |
8.92(4 to 18) |
19.125 |
0.000 |
| poorly-differentiated |
6 |
5.83(4 to 9) |
|
|
| Tumor maximum diameter (cm) |
|
|
|
|
| ≤ 3 cm |
20 |
14.35(7 to 24) |
31.337 |
0.620 |
| > 3 cm |
26 |
7.04(4 to 11) |
|
|
| Gallbladder stones |
|
|
|
|
| no |
18 |
8.22(4 to 12) |
3.730 |
0.053 |
| yes |
28 |
11.50(4 to 24) |
|
|
| TNM stage |
|
|
|
|
| I + II |
12 |
17.00(9 to 24) |
|
|
| III |
20 |
9.20(7 to 15) |
51.139 |
0.000 |
| IV |
14 |
5.86(4 to 8) |
|
|
| Lymph node metastasis |
|
|
|
|
| no |
17 |
14.24(4 to 24) |
16.219 |
0.000 |
| yes |
29 |
7.86(4 to 15) |
|
|
| Invasion |
|
|
|
|
| no |
16 |
15.75(9 to 24) |
32.271 |
0.000 |
| yes |
30 |
7.27(4 to 12) |
|
|
| Surgical |
|
|
|
|
| radical |
|
16.64(10 to 24) |
|
|
| palliative |
|
8.50(6 to 12) |
50.165 |
0.000 |
| biopsy |
|
6.00(4 to 8) |
|
|
| CCT2 |
|
|
|
|
| - |
23 |
12.96(6 to 24) |
14.073 |
0.000 |
| + |
33 |
7.48(4 to 12) |
|
|
| PDIA3 |
|
|
|
|
| - |
20 |
12.75(6 to 24) |
7.011 |
0.008 |
| + | 26 | 8.27(4 to 24) |